Mannkind (MNKD) EBIT Margin Growth (1y) (2017 - 2026)
Mannkind (MNKD) EBIT Margin Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -3,030.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,030.00 |
| Dec 31, 2025 | -4,138.00 |
| Sep 30, 2025 | 480.00 |
| Jun 30, 2025 | -1,602.00 |
| Mar 31, 2025 | 322.00 |
| Dec 31, 2024 | 2,107.00 |
| Sep 30, 2024 | 826.00 |
| Jun 30, 2024 | 1,941.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 4,891.00 |
| Sep 30, 2023 | 3,922.00 |
| Jun 30, 2023 | 11,180.00 |
| Mar 31, 2023 | 16,249.00 |
| Dec 31, 2022 | 15,604.00 |
| Sep 30, 2022 | 39.00 |
| Jun 30, 2022 | -6,413.00 |
| Mar 31, 2022 | -14,174.00 |
| Dec 31, 2021 | -6,276.00 |
| Sep 30, 2021 | 2,980.00 |
| Jun 30, 2021 | 391,337.00 |